All Stories

  1. The Impact of a Nutritional Intervention on Glycemic Control and Cardiovascular Risk Markers in Type 2 Diabetes
  2. Correlation between estimated pulse wave velocity values from two equations in healthy and under cardiovascular risk populations
  3. Effects of Mindful Eating in Patients with Obesity and Binge Eating Disorder
  4. Nutritional Strategies for the Management of Type 2 Diabetes Mellitus: A Narrative Review
  5. Evaluation of Central Hemodynamics in the Diagnosis and Treatment of Hypertension
  6. Diretrizes Brasileiras de Medidas da Pressão Arterial Dentro e Fora do Consultório – 2023
  7. EXPRESSION OF MICRO-RNA 221 AND 223 IN ISCHEMIC STROKE DUE HYPERTENSIVE EMERGENCY
  8. ARTERIAL STIFFNESS IN NORMOTENSIVE PATIENTS WITH HYPOPARATHYROIDISM COMPARED TO CONTROLS
  9. SEQUENTIAL NEPHRON BLOCKADE VERSUS DUAL RENIN-ANGIOTENSIN SYSTEM BLOCKADE IN TRUE RESISTANT HYPERTENSIVE PATIENTS: A SYSTEMATIC REVIEW
  10. EVALUATION OF DEPENDENCE OF AGE AND PERIPHERAL BLOOD PRESSURE IN TWO PULSE WAVE VELOCITY ESTIMATION METHODS
  11. The Effect of Transcutaneous Electrical Nerve Stimulation in Peripheral and Central Hemodynamic Parameters on Resistant Hypertension: A Case Report
  12. The Role of Heart Rate Variability (HRV) in Different Hypertensive Syndromes
  13. Effect of Sequential Nephron Blockade versus Dual Renin-Angiotensin System Blockade Plus Bisoprolol in the Treatment of Resistant Hypertension, a Randomized Controlled Trial (Resistant Hypertension on Treatment - ResHypOT)
  14. Editorial: The importance of the central hemodynamic in the cardiovascular diseases development
  15. Inflammatory cytokines are associated to lower glomerular filtration rate in patients with hypertensive crisis
  16. Linear and non-linear analyses of autonomic modulation in uncontrolled and controlled elderly resistant hypertensives
  17. Alterations in pro- and anti-inflammatory mediators are involved in microvascular dysfunction in postmenopausal women with type 2 diabetes mellitus
  18. Smoking and Endothelial Dysfunction: An Integrated - Medical and Molecular Review
  19. CRISES HIPERTENSIVAS: MITOS, VERDADES E CONDUTAS
  20. HIPERTENSÃO E DIABETES: CONCEITOS ATUAIS NA TERAPÊUTICA
  21. Predictive Factors for Target Organ Injuries in Hypertensive Individuals
  22. Diretrizes Brasileiras de Hipertensão Arterial – 2020
  23. Evidence of Nonadherence in Cases of Pseudoresistant Hypertension
  24. Implications for Clinical Practice from a Multicenter Survey of Heart Failure Management Centers
  25. QUAL O PAPEL DO BLOQUEIO SEQUENCIAL DO NÉFRON NA HIPERTENSÃO RESISTENTE?
  26. Avaliação do Seguimento de 1 Ano dos Pacientes Incluídos no Registro da Prática Clínica em Pacientes de Alto Risco Cardiovascular (REACT)
  27. Effectiveness of chlorthalidone/amiloride versus losartan in patients with stage I hypertension and diabetes mellitus: results from the PREVER-treatment randomized controlled trial
  28. Randomized Study Comparing Vildagliptin vs Glibenclamide on Glucose Variability and Endothelial Function in Patients with Type 2 Diabetes Mellitus and Hypertension
  29. Abstract P081: Expression Of Micro-rnas And Transfer Of Lipids To HDL In Vitro In Stroke Due To Hypertensive Emergency
  30. May Measurement Month 2018: an analysis of blood pressure screening results from Brazil
  31. Posicionamento Luso-Brasileiro de Emergências Hipertensivas – 2020
  32. Plasma levels of matrix metalloproteinase-9 are elevated in individuals with hypertensive crisis
  33. Posicionamento Brasileiro sobre Hipertensão Arterial Resistente – 2020
  34. Central Hemodynamic Parameters are Altered in Resistant Hypertensive Individuals
  35. CRISES HIPERTENSIVAS: DEFININDO A GRAVIDADE E O TRATAMENTO
  36. Effect of vildagliptin versus glibenclamide on endothelial function and arterial stiffness in patients with type 2 diabetes and hypertension: a randomized controlled trial
  37. Effectiveness of low-dose diuretics for blood pressure reduction to optimal values in prehypertension
  38. Controlled Versus Uncontrolled Resistant Hypertension: Are They in the Same Bag?
  39. Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension – study protocol for a randomized cont...
  40. Prevalence of Physical Inactivity and its Effects on Blood Pressure and Metabolic Parameters in a Brazilian Urban Population
  41. Do thiazide diuretics reduce central systolic blood pressure in hypertension?
  42. Effects of acute blood pressure elevation on biochemical-metabolic parameters in individuals with hypertensive crisis
  43. I Luso-Brazilian Positioning on Central Arterial Pressure
  44. Endothelial Changes in Individuals with Prehypertension
  45. How to Investigate the Vascular Changes in Resistant Hypertension
  46. Spotlight on valsartan–sacubitril fixed-dose combination for heart failure: the evidence to date
  47. Angiotensin-converting enzyme insertion/deletion polymorphism, 24-h blood pressure profile and left ventricular hypertrophy in hypertensive individuals: a cross-sectional study
  48. DPP-4 Inhibitor Reduces Central Blood Pressure in a Diabetic and Hypertensive Patient
  49. PP.28.15
  50. Effect of transcutaneous electrical nerve stimulation on peripheral to central blood pressure ratio in healthy subjects
  51. Blockade of Renin Angiotensin System in Heart Failure Post-Myocardial Infarction: What is the Best Therapy?
  52. Prevalence of Metabolic Syndrome: Association with Risk Factors and Cardiovascular Complications in an Urban Population
  53. Is There an Association between Periodontitis and Hypertension?
  54. Nebivolol reduces central blood pressure in stage I hypertensive patients: experimental single cohort study
  55. Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
  56. Renin Angiotensin System Blockage Associates with Insertion/Deletion Polymorphism of Angiotensin-Converting Enzyme in Patients with Hypertensive Emergency
  57. Evidence-Based Therapy Prescription in High-Cardiovascular Risk Patients: The REACT Study
  58. Carotid intima-media thickness is associated with cognitive deficiency in hypertensive patients with elevated central systolic blood pressure
  59. Urinary albumin excretion regression in hypertensive individuals
  60. Hyperglycemia in patients with hypertensive crisis: Response to “Hypertensive crisis: Comparison between diabetics and non-diabetics”
  61. Fatores associados ao aumento no índice de incremento de pressão radial em indivíduos hipertensos
  62. Gene Variation in Resistant Hypertension: Multilocus Analysis of the Angiotensin 1-Converting Enzyme, Angiotensinogen, and Endothelial Nitric Oxide Synthase Genes
  63. Is There An Association Between Vitamin D and Hypertension?
  64. Prevention of hypertension in patients with pre-hypertension: protocol for the PREVER-prevention trial
  65. Hypertensive crisis: clinical–epidemiological profile
  66. Factors associated with impaired urinary albumin excretion in hypertensive individuals
  67. Prevalência e fatores de risco para hipertensão em uma população urbana brasileira
  68. ARTERIAL AND VENOUS ENDOTHELIAL DYSFUNCTION IN RESISTANT HYPERTENSIVE PATIENTS
  69. Coronary emergency and diabetes as manifestations of pheochromocytoma
  70. Ausência de descenso noturno se associa a acidente vascular cerebral e infarto do miocárdio
  71. Evaluation of the awareness, control and cost-effectiveness of hypertension treatment in a Brazilian city: populational study
  72. Factors associated to patients' noncompliance with hypertension treatment
  73. Dissecção aguda de aorta como apresentação de emergência hipertensiva
  74. Prevalência e fatores sociodemográficos em hipertensos de São José do Rio Preto - SP
  75. Disfunção cognitiva após cirurgia cardíaca
  76. H 023 α-ADDUCIN GENETIC VARIANTS AND RISK FACTORS IN SYSTEMIC HYPERTENSION
  77. H 031 THE PREVALENCE OF METABOLIC SYNDROME IN PATIENTS SUFFERING FROM HYPERTENSIVE CRISES
  78. H 024 POLYMORPHISMS OF THE ACE INSERTION/DELETION, M235T ANGIOTENSINOGEN AND ENOS GLU298ASP GENES IN REFRACTORY HYPERTENSION
  79. H 025 EVALUATION OF ENDOTHELIAL FUNCTION AND VASCULAR THICKNESS IN REFRACTORY HYPERTENSIVE PATIENTS
  80. H 026 CARDIOVASCULAR REMODELING (CONCENTRIC LEFT VENTRICLE HYPERTROPHY AND INCREASE IN THE INTIMA-MEDIA THICKNESS) IN REFRACTORY HYPERTENSION
  81. H 029 ACE GENETIC POLYMORPHISMS IN PATIENTS SUFFERING HYPERTENSIVE CRISES
  82. H 036 CARDIOVASCULAR RISK STRATIFICATION IN PATIENTS WITH REFRACTORY ARTERIAL HYPERTENSION
  83. Infarto agudo do miocárdio e dissecção aguda de aorta: um importante diagnóstico diferencial
  84. Perfil de crise hipertensiva: prevalência e apresentação clínica
  85. Adenoma de Conn: uma causa de hipertensão e hipocalemia